28bio, Inc.
Biotechnology company · Metairie, Louisiana, United States
28bio, Inc. is a biotechnology company headquartered in Metairie, Louisiana, United States. Its earliest recorded incorporation is in 2018. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $3 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $6.5 million sold in a notice filed in 2026.
28bio at a glance
What does 28bio do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $3 million in total (2016 to 2022). NIH funding came from the National Center for Advancing Translational Sciences, National Institute of Environmental Health Sciences.
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $6.5 million sold (2026).
Frequently asked questions about 28bio
Where is 28bio headquartered?
28bio, Inc. is headquartered in Metairie, Louisiana, United States.
What does 28bio do?
28bio, Inc. is a biotechnology company.
When was 28bio founded?
The earliest incorporation on record for 28bio, Inc. is in 2018, according to public company registers.
Similar companies
- Waypath Pharma LLCMetairie, Louisiana, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences